Current issues in chemotherapy: the taxanes, platinum compounds, and oxazaphophorines: introduction
Kearns, C.M.
PharmacoTherapy 17(5 Pt 2): 93S-95S
1997
ISSN/ISBN: 0277-0008 PMID: 9322875 Document Number: 479122
Document emailed within 1 workday
Related Documents
Presnov, M.A.; Konovalova, A.L.; Korol'chuk, V.P. 1979: Complex compounds of platinum in the chemotherapy of malignant tumors Vestnik Akademii Meditsinskikh Nauk SSSR 2: 68-80Furukawa, S.; Yoshida, T.; Tukuda, M.; Yanoma, S.; Ryo, I.; Miyata, K.; Kubota, A.; Mochimatsu, I.; Sawaki, S. 1989: Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 1): 419-422
Gale, G.R.; Atkins, L.M.; Meischen, S.J.; Smith, A.B.; Walker, E.M. 1977: Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents Cancer Treatment Reports 61(3): 445-450
Gorbunova, V.A. 1989: Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors Voprosy Onkologii 35(3): 325-330
Hong, R.; Ma, F.; Shi, X.; Li, Q.; Zhang, P.; Yuan, P.; Wang, J.; Fan, Y.; Cai, R.; Li, Q.; Xu, B. 2014: Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs Zhonghua Zhong Liu Za Zhi 36(10): 788-792
Hannemann, J.; Baumann, K. 1988: Inhibition of lactate-dehydrogenase by cisplatin and other platinum-compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitro Research Communications in Chemical Pathology and Pharmacology 60(3): 371-379
Iida, M.; Doi, H.; Asamoto, S.; Sugiyama, H.; Sakagami, H.; Kuribayashi, N.; Takeda, M.; Okamura, Y.; Matsumoto, K. 1999: Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines Anticancer Research 19(6b): 5383-5384
Milling, R.N. 1994: Special issue: current issues in psychiatry Part 2: Introduction and cover story Journal of the South Carolina Medical Association 90(3): 93-95
Koroleva, I.A.; Mochalova, A.S. 2011: Support of hematological homeostasis during chemotherapy with taxanes Voprosy Onkologii 57(6): 784-788
Bozhok, A.A.; Semiglazov, V.F.; Kletzel', A.E.; Arzumanov, A.S.; Mel'nikova, O.A.; Paltuev, R.M.; Ivanova, O.A.; Semiglazov, V.V. 2006: Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer Voprosy Onkologii 52(1): 7-14
Espié, M.; Cuvier, C.; Gorins, A.; Marty, M. 1998: Taxanes in the treatment of breast and ovarian cancers: current indications and results Contraception Fertilite Sexualite 26(11): 805-811
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Kolesova, G.M.; Zakharova, I.A.; Raĭkhman, L.M.; Moshkovskiĭ, I.S. 1979: Effect of platinum and palladium compounds on mitochondrial enzymatic systems Voprosy Meditsinskoi Khimii 25(5): 537-540
Muggia, F.M.; Muderspach, L. 1994: Platinum compounds in cervical and endometrial cancers: focus on carboplatin Seminars in Oncology 21(2 Suppl 2: 35-41; Quiz 42, 58
Akaza, H.; Saijo, N.; Aiba, K.; Isonishi, S.; Ohashi, Y.; Kawai, K.; Konishi, T.; Saeki, T.; Sone, S.; Tsukagoshi, S.; Tsuruo, T.; Noguchi, S.; Miki, T.; Mikami, O.; Smith, M.; Hoctin-Boes, G.; Stribling, D. 2001: Platinum compounds in cancer therapy--past, present, and future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 625-635
Rosenberg, B.; VanCamp, L. 1970: The successful regression of large solid sarcoma 180 tumors by platinum compounds Cancer Research 30(6): 1799-1802
Wright, M.; Lacorre-Arescaldino, I.; Macquet, J.P.; Daffé, M. 1984: Induction of polyploid nuclei in the plasmodium of Physarum polycephalum by platinum antitumor compounds Cancer Research 44(2): 777-783
Bruevich, T.S.; Bogomolets, N.N.; Berezovskiĭ, A.D. 1980: Sensitizing action of precious metal compounds: gold, platinum, ruthenium, rhodium and silver Gigiena Truda i Professional'nye Zabolevaniya (5): 42-44